Skip to content

#MDR transporter

1 public question tagged with this topic.

Which transporter is involved in multidrug resistance (MDR)?

Multidrug resistance in oncology frequently originates from increased efflux reducing intracellular drug accumulation below cytotoxic threshold. ATP-binding cassette transporters, particularly ABCB1 P-glycoprotein, ABCC1 MRP1 and ABCG2 BCRP, are major contributors. They are primary active pumps using two ATP hydrolysis events per cycle to switch transmembrane domains from high-affinity inward-facing to low-affinity outward-facing state, literally vacuuming hydrophobic substrates from inner membrane leaflet. Their drug-binding pocket is large, flexible and polyspecific, accommodating anthracycl

Ref: Gottesman et al., Nat Rev Cancer 2002, Multidrug resistance; Ambudkar et al., Annu Rev Pharmacol 1999.